ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,680 | -20.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $8,390 | -15.5% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q1 2023 | $9,930 | +42.7% | 1,000 | 0.0% | 0.01% | +20.0% |
| Q4 2022 | $6,960 | +30.3% | 1,000 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $5,340 | +33.8% | 1,000 | 0.0% | 0.01% | +66.7% |
| Q2 2022 | $3,990 | -10.2% | 1,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $4,445 | -44.4% | 1,000 | -50.0% | 0.00% | -42.9% |
| Q4 2021 | $8,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |